Quality of Medicines in Portugal: A Retrospective Review of Medicine Recalls (2000–2015)

Reference

1. 1.↵
   1. Almuzaini T.,
   2. Sammons H.,
   3. Choonara I.

   Substandard and Falsified Medicines in the UK: A Retrospective Review of Drug Alerts (2001–2011). BMJ Open 2013, 3 (7), 1–9.

   OpenUrlCrossRef
2. 2.↵
   1. Almuzaini T.,
   2. Sammons H.,
   3. Choonara I.

   Quality of Medicines in Canada: A Retrospective Review of Risk Communication Documents (2005–2013). BMJ Open 2014, 4 (10), 1–9.

   OpenUrlCrossRef
3. 3.↵
   1. Johnston A.

   Substandard Drugs: A Potential Crisis for Public Health. Brit. J. Clin. Pharm. 2013, 78 (2), 218–243.

   OpenUrl
4. 4.↵
   1. Attaran A.,
   2. Barry D.,
   3. Basheer S.,
   4. Benton D.,
   5. Chauvin J.,
   6. Garrett L.,
   7. Kickbusch I.,
   8. Kohler J. C.,
   9. Midha K.,
   10. Newton P. N.,
   11. Nishtar S.,
   12. Orhii P.,
   13. McKee M.

   How to Achieve International Action on Falsified and Substandard Medicines. BMJ 2012, 345, e7381.

   OpenUrlFREE Full Text
5. 5.↵
   www.infarmed.pt, accessed December 2015.